The Regulatory Affairs Team at Rare Disease Research is responsible for navigating the complex landscape of regulatory requirements to ensure compliance for clinical trials involving rare diseases. This team collaborates with government agencies, manages submissions for investigational new drugs, and provides strategic guidance to facilitate patient access to innovative therapies. Their expertise is crucial in advocating for the needs of rare disease patients throughout the regulatory process.
View all